Search - tctmd.com

Displaying 281 - 300 of 320

Sort: Relevancy | Date

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Todd Neale

May 11, 2017

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

News Daily News

Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines

Todd Neale

February 03, 2017

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Shelley Wood

January 19, 2017

News Daily News

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Michael O'Riordan

January 17, 2017

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Shelley Wood

January 04, 2017

News Daily News

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

L.A. McKeown

December 01, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Shelley Wood

November 16, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

Michael O'Riordan

September 30, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

News Industry News

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

June 27, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

Advertisement

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content